Levels of Advanced Oxidation Protein Products in Blood Plasma of Peri- and Postmenopausal Women with Insomnia

Background. Insomnia occurs in more than half of menopausal women. These disorders can contribute to a change in the prooxidant-antioxidant balance, causing the damage to structural cellular elements. Currently, there is a lack of research on this issue.

Aim. To carry out a comparative analysis of the level of advanced oxidation protein products in in periand postmenopausal women with insomnia.

Materials and methods. The study included peri(n = 30) and postmenopausal (n = 60) women, who were divided into 2 groups (control and main groups) in each menopausal phase after being questioned using special sleep questionnaires: Insomnia Severity Index; Epworth Sleepiness Scale; Munich Chronotype Questionnaire. The advanced oxidation protein products (AOPP) levels was determined by immunoenzymatic assay using ImmunDiagnostik (German) kits on a BioTek EL×808 (USA) analyzer. Statistical analysis was performed using Mann – Whitney test.

Results. Comparative analysis of the AOPP levels in control groups, depending on the menopausal periods, showed an increase in their levels in the postmenopausal period as compared to perimenopause (p < 0.05). When comparing the AOPP levels between the control and the main group in different menopausal periods, statistically significant differences were revealed only in the perimenopausal period towards a higher content in women with insomnia (p < 0.05). The presence of insomnia in postmenopausal women is accompanied by a higher AOPP levels as compared to the perimenopausal women (p < 0.05).

Conclusion. The obtained results indicate the association between insomnia and oxidative proteins modification only in the perimenopausal period.

1. Gracia CR, Freeman EW. Onset of the menopause transition: The earliest signs and symptoms. Obstet Gynecol Clin North Am. 2018; 45(4): 585-597. doi: 10.1016/j.ogc.2018.07.002

2. Lumsden MA, Sassarini J. The evolution of the human menopause. Climacteric. 2019; 22(2): 111-116. doi: 10.1080/1369-7137.2018.1547701

3. Kumar S, Lata K, Mukhopadhyay S, Mukherjee TK. Role of estrogen receptors in pro-oxidative and anti-oxidative actions of estrogens: A perspective. Biochim Biophys Acta Gen Subj. 2010; 1800: 1127-1135. doi: 10.1016/j.bbagen.2010.04.011

4. Jehan S, Jean-Louis G, Zizi F, Auguste E, Pandi-Perumal SR, Gupta R, et al. Sleep, melatonin, and the menopausal transition: what are the links? Sleep Sci. 2017; 10(1): 11-18. doi: 10.5935/19840063.20170003

5. Semenova NV, Madaeva IM, Kolesnikova L. Insomnia and circadian rhythms of melatonin in menopausal women. Acta Biomedica Scientifica. 2018; 3(5): 16-21. doi: 10.29413/ABS.2018-3.5.2

6. Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L. Melatonin as an antioxidant: under promises but over delivers. J Pineal Res. 2016; 61(3): 253-278. doi: 10.1111/jpi.12360

7. Kolesnikova LI, Semenova NV, Solodova EI, Madaeva IM. Oxidative stress in women with insomnia in different stages of menopause. Terapevticheskii arkhiv. 2017; 89(8): 50-56. doi: 10.17116/terarkh201789850-56. (In Russ.)

8. Gaschler MM, Stockwell BR. Lipid peroxidation in cell death. Biochem Biophys Res Commun. 2017; 482(3): 419-425. doi: 10.1016/j.bbrc.2016.10.086

9. Ovodenko DL, Svarev EG, Dikareva LV. Determination diagnostic value of carbonyl proteins in the biological liquids of patients with ovarian tumors. Journal of Obstetrics and Women’s Diseases. 2008; 57(3): 50-54. (In Russ.)

10. Gubskiy YuI, Belenichev IF, Levitskiy EL. Toxicological consequences of oxidative modification of proteins in various pathological conditions (literature review). Modern Problems of Toxicology. 2005; 8(3): 20. (In Russ.)

11. Davydov VV, Bozhkov AI. Carbonyl stress is a nonspecific factor of pathogenesis (review of literature and own data). Journal of the National Academy of Medical Sciences of Ukraine. 2014; 20(1): 25-34. (in Russ.)

12. Semenova NV, Madaeva IM, Kolesnikova LI. Free radical oxidation and sleep disorders in androand menopause (literature review). Acta Biomedica Scientifica. 2020; 5(1): 31-41. doi: 10.29413/ABS.2020-5.1.4. (In Russ.)

13. Gopalakrishnan A, Cirelli C. Sleep deprivation and cellular responses to oxidative stress. Sleep. 2004; 27(1): 27-35. doi: 10.1093/sleep/27.1.27

14. Sukhikh GT, Smetnik VP, Yureneva SV, Ermakova EI, Chernukha GE, Yakushevskaya OV. Menopause and climacteric state in women. Clinical guidelines. Мoscow; 2016. (In Russ.)

15. Tarasova MA, Yarmolinskaya MI. Principles of individual choice of hormone replacement therapy in periand postmenopausal women. Saint Petersburg; 2006. (In Russ.)

16. Johns MW. New method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991; 14: 540-545. doi: 10.1093/sleep/14.6.540

17. Morin C, Simard S, Savard J. Insomnia. In: Nikcevic AV, Kuczmierczyk AR, Bruch M (eds.). Formulation and treatment in clinical health psychology. London: Routledge; 2006: 61-86.

18. Zavada A, Gordijn MC, Beersma DG, Daan S, Roenneberg T. Comparison of the Munich Сhronotype Questionnaire with the Horne – Ostberg’s Morningness – Eveningness Score. Chronobiology Int. 2005; 22(2): 267-278. doi: 10.1081/cbi-200053536

19. Poluektov MG, Buzunov RV, Averbukh VM, Verbitskiy EV, Zakharov AV, Kelmanson IA, et al. Project of clinical recommendations on diagnosis and treatment of chronic insomnia in adults. Neurology and Rheumatology (Suppl.). 2016; 2: 41-51. (in Russ.)

20. Semenova NV, Madaeva IM, Darenskaya MA, Kolesnikova LI. Lipid peroxidation and antioxidant defense system in menopausal women of different ethnic groups. Human Ecology. 2019; 6: 30-38. doi: 10.33396/1728-0869-2019-6-30-38. (In Russ.)

21. Sanchez-Rodriguez MA, Zacarias-Flores M, Arronte-Rosales A, Mendoza-Nunez VM. Association between hot flashes severity and oxidative stress among Mexican postmenopausal women: A cross-sectional study. PLoS One. 2019; 14(9): e0214264. doi: 10.1371/journal.pone.0214264

22. Victorino VJ, Panis C, Campos FC, Cayres RC, Colado-Simão AN, Oliveira SR, et al. Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women. Age (Dordr). 2013; 35(4): 1411-1421. doi: 10.1007/s11357-012-9431-9

23. Cakir T, Goktas B, Mutlu MF, Mutlu I, Bilgihan A, Erdem M, et al. Advanced oxidation protein products and malondialdehyde – the new biological markers of oxidative stress – are elevated in postmenopausal women. Ginekol Pol. 2016; 87(5): 321-325. doi: 10.5603/GP.2016.0001

24. Montoya-Estrada A, Velazquez-Yescas KG, Veruete-Bedolla DB, Ruiz-Herrera JD, Villarreal-Barranca A, Romo-Yañez J, et al. Parameters of oxidative stress in reproductive and postmenopausal Mexican women. Int J Environ Res Public Health. 2020; 17(5): 1492. doi: 10.3390/ijerph17051492

25. Hachul de Campos H, Brandao LC, D’Almeida V, Grego BH, Bittencourt LR, Tufik S, et al. Sleep disturbances, oxidative stress and cardiovascular risk parameters in postmenopausal women complaining of insomnia. Climacteric. 2006; 9(4): 312-319. doi: 10.1080/13697130600871947

26. Polac I, Borowiecka M, Wilamowska A, Nowak P. Oxidative stress measured by carbonyl groups level in postmenopausal women after oral and transdermal hormone therapy. J Obstet Gynaecol Res. 2012; 38(9): 1177-1181. doi: 10.1111/j.1447-0756.2011.01842.x

27. Fedorova M, Bollineni RC, Hoffmann R. Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies. Mass Spectrom Rev. 2014; 33(2): 79-97. doi: 10.1002/mas.21381